Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Bont

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
Nature Communications|March 17, 2024
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virusGu-Lung Lin, Simon B Drysdale, Matthew D Snape, et al.
Frontiers in Immunology|November 4, 2024
Serum and mucosal antibody-mediated protection and identification of asymptomatic respiratory syncytial virus infection in community-dwelling older adults in EuropeDeniz Öner, Charlotte Vernhes, Sunita Balla-Jhagjhoorsingh, et al.
Nature Communications|February 13, 2025
Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemicChenkai Zhao, Tiantian Zhang, Ling Guo, et al.
Cell Reports. Medicine|December 6, 2024
The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in childrenMaartje Kristensen, Wouter A A de Steenhuijsen Piters, Joanne Wildenbeest, et al.
American Journal of Respiratory and Critical Care Medicine|March 19, 2024
Respiratory Syncytial Virus-related Community Chronic Obstructive Pulmonary Disease Exacerbations and Novel Diagnostics: A Binational Prospective Cohort StudyDexter J Wiseman, Ryan S Thwaites, Andrew I Ritchie, et al.
The Lancet. Infectious Diseases|December 23, 2023
Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysisBingbing Cong, Uğurcan Koç, Teresa Bandeira, et al.
The Journal of Infectious Diseases|August 15, 2020
Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU)Kimberley Jefferies, Simon B Drysdale, Hannah Robinson, et al.
Vaccine|January 25, 2020
Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meetingAmanda J Driscoll, S Hasan Arshad, Louis Bont, et al.
BMC Infectious Diseases|February 15, 2022
Analysing the protection from respiratory tract infections and allergic diseases early in life by human milk components: the PRIMA birth cohortArthur H van Stigt, Katrien Oude Rengerink, Kitty W M Bloemenkamp, et al.
American Journal of Respiratory Cell and Molecular Biology|July 7, 2026
Protocadherin-1 deficiency increases baseline and allergen-induced airway hyperresponsiveness in miceBao-Han Ly, Uilke Brouwer, Laura Hesse, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Nature Communications|March 17, 2024
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virusGu-Lung Lin, Simon B Drysdale, Matthew D Snape, et al.
Frontiers in Immunology|November 4, 2024
Serum and mucosal antibody-mediated protection and identification of asymptomatic respiratory syncytial virus infection in community-dwelling older adults in EuropeDeniz Öner, Charlotte Vernhes, Sunita Balla-Jhagjhoorsingh, et al.
Nature Communications|February 13, 2025
Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemicChenkai Zhao, Tiantian Zhang, Ling Guo, et al.
Cell Reports. Medicine|December 6, 2024
The respiratory microbiome is linked to the severity of RSV infections and the persistence of symptoms in childrenMaartje Kristensen, Wouter A A de Steenhuijsen Piters, Joanne Wildenbeest, et al.
American Journal of Respiratory and Critical Care Medicine|March 19, 2024
Respiratory Syncytial Virus-related Community Chronic Obstructive Pulmonary Disease Exacerbations and Novel Diagnostics: A Binational Prospective Cohort StudyDexter J Wiseman, Ryan S Thwaites, Andrew I Ritchie, et al.
The Lancet. Infectious Diseases|December 23, 2023
Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysisBingbing Cong, Uğurcan Koç, Teresa Bandeira, et al.
The Journal of Infectious Diseases|August 15, 2020
Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU)Kimberley Jefferies, Simon B Drysdale, Hannah Robinson, et al.
Vaccine|January 25, 2020
Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meetingAmanda J Driscoll, S Hasan Arshad, Louis Bont, et al.
BMC Infectious Diseases|February 15, 2022
Analysing the protection from respiratory tract infections and allergic diseases early in life by human milk components: the PRIMA birth cohortArthur H van Stigt, Katrien Oude Rengerink, Kitty W M Bloemenkamp, et al.
American Journal of Respiratory Cell and Molecular Biology|July 7, 2026
Protocadherin-1 deficiency increases baseline and allergen-induced airway hyperresponsiveness in miceBao-Han Ly, Uilke Brouwer, Laura Hesse, et al.
Pageof 18